Michael Frimpong

Research Spotlight💡 Michael Frimpong, #APTI Fellow & #Molecular #Immunologist from #Ghana is working on the microbiome of skin Neglected Tropical Diseases #SkinNTDs to inform treatment and control strategies. Learn more👉shorturl.at/atCDV @Fogarty_NIH @GatesAfrica @KNUSTGH

Addressing #NTDs requires investing in research and development #R&D for better treatments and diagnostics. By #InnovatingTogether, we can bring the best #science to the most neglected. #AASciences #BeatNTDs @Fogarty_NIH @gatesfoundation @WHOAFRO @DNDi

Dr Frimpong #AfricanResearcher from #Ghana based at Kwame Nkrumah University of Science & Technology @KNUSTGH is using his #APTI fellowship to conduct research on microbiome, respiratory infections & #bioinformatics. #GlobalHealth #ScienceLeadership @Fogarty_NIH @GatesAfrica

Let continue the fight against NTDs during this difficult period of COVID-19 pandemic..

Reflecting on #WorldNTDDay2022 we celebrate the progress made Dr Michael Frimpong’s experience in #NTD diagnosis was used in Ghana’s COVID-19 response His fellowship on buruli ulcer was briefly halted but now successfully completed ✅ @Mfrimpong @KNUSTGH youtube.com/watch?v=EO_I0f…

Dr Michael Frimpong - Follow the Fellow in times of COVID-19 youtu.be/EO_I0fAU4iI via @YouTube @KNUSTGH @afri_dx @skin_africa @BU_LabNet

Dr. Michael Frimpong, a Molecular Immunologist lecturer at the Department of Molecular Medicine, School of Medicine and Dentistry, KNUST has been named among the Ten grantees of the 2020 African Postdoctoral Training Initiative (APTI). Read more: bit.ly/drFrimpong

The African Postdoctoral Training Initiative #APTI will soon welcome its 2nd cohort of 10 fellows from 7 African countries to @NIH. @AASciences @gatesfoundation & #NIH are partners. @NIHClinicalCntr @NIAIDNews & @genome_gov will host fellows. fic.nih.gov/News/Pages/202…

#TropicalmedMDPI @UniLeipzig, @KNUSTGH Special Issue "#Point of #Need #Testing of Infectious Diseases" More details：mdpi.com/journal/tropic… Submission deadline: 31 October 2021

AddThis | Home authors.elsevier.com/a/1cVcz,2UvpTf…

Kudos to the team

In a new paper from @skin_africa member @Mfrimpong @KNUSTGH describes validation a new Recombinase Polymerase Assay for #Yaws bit.ly/34KfKOZ Test had promising sensitivity and specificity & might be a useful tool to support #yaws eradication efforts in Ghana & elsewhere

Multiplex Recombinase Polymerase Amplification Assay for Simultaneous Detection of Treponema pallidum and Haemophil… pubmed.ncbi.nlm.nih.gov/33036234/

Glad to be part of this network, time to deepen south-south cooperation

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial thelancet.com/journals/lance…

Let’s be grateful for the tireless work of scientists worldwide in tackling #coronavirus. The US National Pubmed website lists over 650 references to papers on coronavirus, which dwarfs the comparable literature on previous viral epidemics. pubmed.ncbi.nlm.nih.gov/?term=Covid-19…

The unprecedented gains we have made against NTDs show what is possible when a diverse group of partners rally around a common goal. Together, we can #beatNTDs.

Excited announce @officialNIHR collaboration @LSHTM @KNUSTGH @NMIMR_UG @AHRI_ETH Tackle Skin #NTDs & stigma Ghana & Ethiopia bit.ly/34A5MOk

Excited to be talking #Scabies @KnustNews Kumasi Ghana - Next week #beatNTDs

#mdpidiagnostics Rapid Extraction Method of Mycobacterium ulcerans DNA from Clinical Samples of Suspected Buruli Ulcer Patients mdpi.com/2075-4418/9/4/… @diagnostic_mdpi